Could stem cells offer a lifeline for sudden liver failure?
NCT ID NCT06740149
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study investigates whether infusions of bone marrow stem cells (CG-BM1) can safely help people with acute-on-chronic liver failure, a life-threatening condition where the liver suddenly stops working. The trial involves 90 adults and will test different doses of stem cells given intravenously. Researchers are checking for side effects and whether the treatment can improve survival without needing a liver transplant.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
bone marrow mesenchymal stem cells (CG-BM1)
What this could lead to
If successful, this could offer a new treatment to help people with acute-on-chronic liver failure survive longer without needing a liver transplant.
What could go wrong
This is an early-phase trial, so the stem cell therapy may not work as hoped, and there could be side effects like allergic reactions or infections. The results may not apply to all patients.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ACUTE-ON-CHRONIC LIVER FAILURE are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Third Affliated Hospital of Sun Yat-sen University
Guangzhou, Guangdong, 510630, China